Study potentially links low blood amylin level to reduced progression of Alzheimer’s disease

Study potentially links low blood amylin level to reduced progression of Alzheimer’s disease
Nirmal Verma, Ph.D., and several other researchers contributed to the recent study potentially linking low blood amylin levels to reduced progression of Alzheimer’s disease. Credit: Pete Comparoni | UKphoto

More than 5.7 million Americans live with Alzheimer’s disease and that number is projected to triple by 2050. Despite that growing number, there is not yet a cure.

Florin Despa, a professor with the University of Kentucky’s Department of Pharmacology and Nutritional Sciences, says, “The mechanisms underlying are largely unknown and effective therapies are lacking.” That is why numerous studies and trials are ongoing around the…

Read more…